Lingya Pan
Overview
Explore the profile of Lingya Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Wang D, Wang R, He Y, Jia C, Pan L, et al.
J Ovarian Res
. 2024 May;
17(1):96.
PMID: 38720349
Objective: To describe the characteristics of children and adolescents with borderline ovarian tumors (BOTs) and evaluate the efficacy and safety of fertility-sparing surgery (FSS) in these patients. Methods: Patients with...
2.
Ding X, Li Y, Cao D, Wan X, Wu M, Pan L, et al.
Chin Med J (Engl)
. 2024 Jan;
137(16):1979-1981.
PMID: 38180807
No abstract available.
3.
Wang W, Zhang F, Li Y, Chen B, Gu Y, Shan Y, et al.
Front Oncol
. 2023 Nov;
13:1182029.
PMID: 37920164
Background: Primary small cell neuroendocrine carcinomas of the cervix and endometrium are rare gynecological malignancies with limited treatment options. This study aimed to improve the understanding of the carcinogenesis process...
4.
Cang W, Liang C, Wang D, Xue X, Cao D, Yang J, et al.
J Clin Med
. 2023 Sep;
12(18).
PMID: 37762767
Our study aimed to analyze the prognosis and reproductive outcomes of patients with advanced-stage serous borderline ovarian tumors (SBOTs) who underwent fertility-sparing surgery (FSS). This study included patients aged ≤...
5.
Zhang X, Yang J, Xiang Y, Pan L, Wu M, Cao D, et al.
Int J Gynecol Cancer
. 2023 Sep;
34(1):99-105.
PMID: 37696647
Objective: To compare surgery and survival outcomes between neoadjuvant chemotherapy and primary debulking surgery in patients with advanced ovarian yolk sac tumor. Methods: In this retrospective cohort analysis, patients with...
6.
Li N, Zhu J, Yin R, Wang J, Pan L, Kong B, et al.
JAMA Oncol
. 2023 Jul;
9(9):1230-1237.
PMID: 37440217
Importance: The efficacy of niraparib maintenance therapy with an individualized starting dose (ISD) warrants further investigation in a broad population with newly diagnosed advanced ovarian cancer (aOC), including patients without...
7.
Shan Y, Jin Y, Pan L
Hepatobiliary Surg Nutr
. 2022 Dec;
11(6):924-926.
PMID: 36523920
No abstract available.
8.
Yin J, Li Y, Wang H, Wang W, Gu Y, Jin Y, et al.
Eur J Obstet Gynecol Reprod Biol
. 2022 Nov;
280:83-88.
PMID: 36436458
Background: To evaluate the oncologic and pregnancy outcomes of patients with early stage endometrioid adenocarcinoma (EMC) and atypical endometrial hyperplasia (AEH) treated with controlled ovarian stimulation (COS) with or without...
9.
Chen J, Li Y, Wang H, Li T, Gu Y, Wang W, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230574
(1) The accuracy of patient-derived xenografts (PDXs) in predicting ADP-ribose polymerase inhibitor (PARPi) efficacy in ovarian cancer was tested, novel biomarkers were investigated, and whether PARPis could replace platinum-based chemotherapy...
10.
Shan Y, Jin Y, Li Y, Gu Y, Wang W, Pan L
Front Oncol
. 2022 Sep;
12:980050.
PMID: 36072802
Purpose: Patients with advanced ovarian cancer often undergo en bloc rectosigmoid resection with total hysterectomy to completely debulk the pelvis. We describe a unique rectosigmoid sparing en bloc pelvic resection...